UA83542C2 - Комбинация агомелатина и ингибитора обратного захвата норадреналина и содержащая ее фармацевтическая композиция - Google Patents

Комбинация агомелатина и ингибитора обратного захвата норадреналина и содержащая ее фармацевтическая композиция Download PDF

Info

Publication number
UA83542C2
UA83542C2 UAA200609700A UAA200609700A UA83542C2 UA 83542 C2 UA83542 C2 UA 83542C2 UA A200609700 A UAA200609700 A UA A200609700A UA A200609700 A UAA200609700 A UA A200609700A UA 83542 C2 UA83542 C2 UA 83542C2
Authority
UA
Ukraine
Prior art keywords
agomelatin
inhibitor
combination
pharmaceutical composition
noradrenaline reuptake
Prior art date
Application number
UAA200609700A
Other languages
English (en)
Ukrainian (uk)
Inventor
Элизабет Мокер
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of UA83542C2 publication Critical patent/UA83542C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA200609700A 2005-09-09 2006-09-08 Комбинация агомелатина и ингибитора обратного захвата норадреналина и содержащая ее фармацевтическая композиция UA83542C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509206A FR2890564B1 (fr) 2005-09-09 2005-09-09 Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
UA83542C2 true UA83542C2 (ru) 2008-07-25

Family

ID=36190808

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200609700A UA83542C2 (ru) 2005-09-09 2006-09-08 Комбинация агомелатина и ингибитора обратного захвата норадреналина и содержащая ее фармацевтическая композиция

Country Status (39)

Country Link
US (1) US7622505B2 (ru)
EP (1) EP1769798B1 (ru)
JP (2) JP5395998B2 (ru)
KR (1) KR100863384B1 (ru)
CN (1) CN1927205A (ru)
AP (1) AP2615A (ru)
AR (1) AR056056A1 (ru)
AT (1) ATE404205T1 (ru)
AU (1) AU2006209368B2 (ru)
BR (1) BRPI0603759A (ru)
CA (1) CA2558782C (ru)
CY (1) CY1108319T1 (ru)
DE (1) DE602006002210D1 (ru)
DK (1) DK1769798T3 (ru)
EA (1) EA011650B1 (ru)
ES (1) ES2313590T3 (ru)
FR (1) FR2890564B1 (ru)
GE (1) GEP20094742B (ru)
GT (1) GT200600408A (ru)
HR (1) HRP20080535T3 (ru)
JO (1) JO2521B1 (ru)
MA (1) MA28505B1 (ru)
ME (2) ME02758B (ru)
MX (1) MXPA06010157A (ru)
MY (1) MY142260A (ru)
NO (1) NO338029B1 (ru)
NZ (1) NZ549725A (ru)
PE (1) PE20070429A1 (ru)
PL (1) PL1769798T3 (ru)
PT (1) PT1769798E (ru)
RS (1) RS50631B (ru)
SA (1) SA06270308B1 (ru)
SG (1) SG131030A1 (ru)
SI (1) SI1769798T1 (ru)
TW (1) TWI324513B (ru)
UA (1) UA83542C2 (ru)
UY (1) UY29778A1 (ru)
WO (1) WO2007028904A1 (ru)
ZA (1) ZA200607562B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008247805A1 (en) * 2007-05-01 2008-11-13 Concert Pharmaceuticals Inc. Naphthyl(ethyl) acetamides
WO2008141033A1 (en) * 2007-05-08 2008-11-20 Auspex Pharmaceuticals Inc. Substituted naphthalenes
CN102342924A (zh) * 2010-08-05 2012-02-08 北京本草天源药物研究院 一种含有阿戈美拉汀的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
ZA989251B (en) * 1997-10-17 2000-04-10 Lilly Co Eli Potentiation of pharmaceuticals.
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
JP2005518439A (ja) * 2002-02-26 2005-06-23 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 抗痙攣性誘導体と抗片頭痛薬を含んで成る片頭痛治療用共治療薬
JP2004292445A (ja) * 2003-03-11 2004-10-21 Katsunori Nonogaki 糖尿病治療薬
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
AU2004271796A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Combination comprising an alpha-2-delta ligand and an SSRI and/or SNRI for treatment of depression and anxiety disorders

Also Published As

Publication number Publication date
AU2006209368A1 (en) 2007-03-29
AP2615A (en) 2013-03-14
FR2890564B1 (fr) 2007-10-19
CA2558782C (fr) 2012-05-15
JP2007077147A (ja) 2007-03-29
JP2011088919A (ja) 2011-05-06
CY1108319T1 (el) 2014-02-12
FR2890564A1 (fr) 2007-03-16
DE602006002210D1 (de) 2008-09-25
BRPI0603759A (pt) 2007-05-15
AR056056A1 (es) 2007-09-12
CA2558782A1 (fr) 2007-03-09
JO2521B1 (en) 2010-03-17
EP1769798A1 (fr) 2007-04-04
PE20070429A1 (es) 2007-06-02
AP2008004378A0 (en) 2008-04-30
MXPA06010157A (es) 2007-03-08
GEP20094742B (en) 2009-07-27
ME02767B (me) 2010-06-30
MY142260A (en) 2010-11-15
SA06270308B1 (ar) 2011-10-08
US7622505B2 (en) 2009-11-24
KR100863384B1 (ko) 2008-10-13
JP5395998B2 (ja) 2014-01-22
GT200600408A (es) 2007-05-21
NZ549725A (en) 2008-03-28
DK1769798T3 (da) 2008-11-24
SI1769798T1 (sl) 2008-12-31
NO20064048L (no) 2007-03-12
KR20070029606A (ko) 2007-03-14
PL1769798T3 (pl) 2008-12-31
ES2313590T3 (es) 2009-03-01
ZA200607562B (en) 2008-05-28
CN1927205A (zh) 2007-03-14
ATE404205T1 (de) 2008-08-15
US20070060654A1 (en) 2007-03-15
HRP20080535T3 (en) 2008-12-31
NO338029B1 (no) 2016-07-25
TW200744570A (en) 2007-12-16
MA28505B1 (fr) 2007-04-03
SG131030A1 (en) 2007-04-26
WO2007028904A1 (fr) 2007-03-15
UY29778A1 (es) 2006-10-31
ME02758B (me) 2010-06-30
AU2006209368B2 (en) 2012-07-19
EA011650B1 (ru) 2009-04-28
TWI324513B (en) 2010-05-11
EP1769798B1 (fr) 2008-08-13
RS50631B (sr) 2010-06-30
PT1769798E (pt) 2008-09-18
EA200601410A1 (ru) 2007-04-27

Similar Documents

Publication Publication Date Title
US20070060655A1 (en) Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorders in the depressed patient
CA2777746A1 (en) Benzoimidazole compounds and uses thereof
UA83542C2 (ru) Комбинация агомелатина и ингибитора обратного захвата норадреналина и содержащая ее фармацевтическая композиция
JP2021502392A5 (ru)
RU2006104009A (ru) Фармацевтическая препаративная форма
DK2533774T3 (en) USE OF AGOMELATIN FOR THE PREPARATION OF MEDICINALS FOR THE TREATMENT OF OBSESSIVE-COMPULSIVE CONDITION (OCD)
US7947743B2 (en) Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders
ES2668943T3 (es) Composición farmacéutica para tratar eyaculación precoz y método de tratamiento de la eyaculación precoz
RU2008105972A (ru) Новая соль i
US7902180B2 (en) Association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it
Islam An overview: extent of teratogenicity of common medications in fetal development
Cusin et al. Original Research A Randomized, Double-Blind, Placebo-Controlled Trial
JP2005527634A (ja) 緊張型頭痛の治療にミルナシプランを使用する方法
JANCIN Tricyclics Elevate Metabolic Syndrome Risk
EP2046119A2 (en) Treatment of psychiatric disorders
RU2014127731A (ru) Комбинация 4-{ 3-[цис-гексагидроциклопента[c]пиррол-2(1н)-ил]пропокси} бензамида и антагониста nmda-рецептора и содержащие ее фармацевтические композиции